insights_auto
Why is INCY up 2.53%?
Dive Deeperchevron_right
INCY:NASDAQ
Incyte Corp
$116.12
arrow_upward
+2.53%(+2.87) 1D
Oct 20, 12:42:21 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
$113.78
High
$117.00
Low
$113.26
Mkt. cap
23.54B
Avg. vol.
1.69M
Volume
328.64K
P/E ratio
14.80
52-wk high
$132.58
52-wk low
$84.02
EPS
$7.85
Beta
0.74
Shares outstanding
202.70M
No. of employees
3K
Open
$113.78
High
$117.00
Low
$113.26
Mkt. cap
23.54B
Avg. vol.
1.69M
Volume
328.64K
P/E ratio
14.80
52-wk high
$132.58
52-wk low
$84.02
EPS
$7.85
Beta
0.74
Shares outstanding
202.70M
No. of employees
3K
News stories
From web sources and news partners
Investing.com
·
8 hours ago
Morgan Stanley initiates Incyte stock coverage with Equalweight rating
Investing.com Nigeria
·
10 hours ago
Incyte president Cagnoni sells $297,779 in common stock By Investing.com
www.marketscreener.com
·
19 hours ago
Incyte Insider Sold Shares Worth $297,780, According to a Recent SEC Filing
Stock Titan
·
20 hours ago
An Incyte (INCY) officer exercises options and sells 2,642 shares at $112.71.
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteincyte.com